Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RIGL
#2642
Rigel Pharmaceuticals, Inc. - Common Stock
41.3
0
USD
-0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.94%
Monthly Change
+24.25%
6 month change
+5.90%
Year Change
+37.07%
Previous Close
42.5
5
Open
41.3
0
Low
41.3
0
High
41.3
0
Volume
65
Markets
US Stock Market
Healthcare
Biotechnology
RIGL
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
17 M
17.17 M
17.37 M
17.54 M
17.86 M
18.47 M
18.5 M
Valuation ratios
Enterprise value
584.59 M
455.99 M
247.68 M
282.87 M
303.39 M
802.92 M
818.64 M
Price to earnings ratio
—
-24.09
-3.94
-10.43
16.99
2.2
2.24
Price to sales ratio
—
3.03
1.92
2.17
1.66
2.74
2.71
Price to cash flow ratio
—
76.86
-3.13
44.24
9.45
10.67
10.17
Price to book ratio
—
14.87
-16.97
8.87
90.48
2.06
0.83
Enterprise value to EBITDA ratio
-20.68
-40.23
-4.54
-14.69
11.48
6.28
6.45
Profitability ratios
Return on assets %
-0.27
-0.11
-0.44
-0.21
0.11
0.71
0.02
Return on equity %
-0.87
-0.59
4.3
0.88
5.32
0.94
0.02
Return on invested capital %
-222.99
-90.01
-512.08
-177.93
155.66
441.95
10.35
Gross margin %
99.18
99.27
98.55
93.92
89.6
93.33
92.17
Operating margin %
-26.67
-8.37
-46.2
-17.53
13.49
42.63
20.21
EBITDA margin %
-26.02
-7.59
-45.37
-16.47
14.74
43.46
21.22
Net margin %
-27.38
-12
-48.71
-21.47
9.75
124.72
14.71
Liquidity ratios
Quick ratio
2.14
2.33
1.64
1.76
2.04
2.3
2.48
Current ratio
2.18
2.43
1.78
1.86
2.13
2.42
2.62
Inventory turnover
0.6
0.26
0.22
0.97
3.24
1.71
0.4
Asset turnover
0.84
1.07
0.8
0.93
1.28
0.57
0.12
Solvency ratios
Debt to assets ratio
0.18
0.12
0.29
0.51
0.36
0.1
0.09
Debt to equity ratio
0.58
0.66
-2.9
-2.08
18.15
0.13
0.11
Long term debt to total assets ratio
0.18
0.12
0.3
0.51
0.37
0.1
0.09
Long term debt to total equity ratio
0.59
0.66
-2.94
-2.09
18.25
0.13
0.11
Per share metrics
Operating cash flow per share
—
0.34
-4.28
-0.33
1.78
4.02
4.24
EBIT per share
—
-0.73
-3.22
-1.18
1.37
6.66
6.68
EBITDA per share
—
-0.66
-3.16
-1.11
1.49
6.79
6.81
Total debt per share
—
1.17
2.29
3.43
3.37
2.78
2.28
Cash per share
—
7.33
3.38
3.27
4.37
8.23
7.45
Net current asset value per share
—
9.06
6.72
5.7
7.64
12.75
11.89
Tangible book value per share
—
1.78
-1.66
-2.44
-1.35
19.47
19.09
Working capital per share
—
5.33
2.94
2.64
4.06
7.48
7.34
Book value per share
—
1.78
-0.79
-1.65
0.19
20.78
20.31
News
Bioventus (BVS) Soars 12.4%: Is Further Upside Left in the Stock?
A Look At The Transformation Around Rigel Pharmaceuticals (NASDAQ:RIGL)
Rigel Pharmaceuticals, Inc. (RIGL) M&A Call - Slideshow (NASDAQ:RIGL) 2026-05-20
Rigel Pharmaceuticals, Inc. (RIGL) M&A Call Transcript
Arvinas: FDA Approval Validates The Platform, But Does Not Signal Near-Term Profitability
Rigel Pharmaceuticals (RIGL) Lags Q1 Earnings and Revenue Estimates
Rigel Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:RIGL) 2026-05-05
Guardian Pharmacy Services (GRDN) Reports Next Week: Wall Street Expects Earnings Growth
Rigel Pharmaceuticals (RIGL) to Report Q1 Results: Wall Street Expects Earnings Growth
Is the Options Market Predicting a Spike in Rigel Pharmaceuticals Stock?
Rigel Pharmaceuticals Was Easy To Dismiss - Now It's Hard To Ignore (NASDAQ:RIGL)
Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?